丁酸盐调节肠道微生物群和抗炎反应,减轻顺铂引起的肾损伤

IF 6.9 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Wen-Jung Chen , Yng-Tay Chen , Jiunn-Liang Ko , Jian-Yuan Chen , Jun-Yao Zheng , Jiunn-Wang Liao , Chu-Chyn Ou
{"title":"丁酸盐调节肠道微生物群和抗炎反应,减轻顺铂引起的肾损伤","authors":"Wen-Jung Chen ,&nbsp;Yng-Tay Chen ,&nbsp;Jiunn-Liang Ko ,&nbsp;Jian-Yuan Chen ,&nbsp;Jun-Yao Zheng ,&nbsp;Jiunn-Wang Liao ,&nbsp;Chu-Chyn Ou","doi":"10.1016/j.biopha.2024.117689","DOIUrl":null,"url":null,"abstract":"<div><div>In our previous research, we reported that administering probiotics <em>Lactobacillus reuteri</em> and <em>Clostridium butyricum</em> (LCs) before cisplatin treatment effectively modifies structures of the gut microbiota and restore ecological balance and significantly increases butyrate levels, a process closely associated with reducing cisplatin-induced nephrotoxicity. This study aims to investigate further whether the elevation of metabolite butyrate in the gut, promoted by probiotics LCs, can effectively mitigate the nephrotoxic effects of cisplatin and the progression of renal senescence in rats. Results show that butyrate administration significantly improved kidney function and decreased renal fibrosis in a dose-dependent manner compared to the cisplatin group. Its effects were associated with reductions in inflammatory responses, evidenced by decreased levels of key inflammatory markers, including KIM-1, MPO, NOX2, F4/80, and TGF-β1, alongside increased production of the anti-inflammatory cytokine IL-10. Furthermore, the butyrate intervention ameliorated cisplatin-induced gut microbiota dysbiosis, preserving the structure and diversity of healthy microbial communities. Specifically, we observed a decrease in the abundance of <em>Escherichia_Shigella</em> and <em>Blautia</em>, alongside an increase in the abundance of the butyrate-producing genus <em>Roseburia</em>. Notably, <em>Escherichia_Shigella</em> exhibited a positive correlation with the pro-inflammatory factor MPO, while displaying a negative correlation with the anti-inflammatory cytokine IL-10. Butyrate also attenuated the cisplatin-induced expression of senescence markers p21 and p16 in kidney tissue. It alleviated the cisplatin-increased senescence-associated beta-galactosidase activity and reactive oxygen species production in SV40 MES-13 cells. These results indicate that butyrate, derived from the gut microbiota, may exert a protective effect against cisplatin-induced kidney damage by regulating microbiota balance and anti-inflammatory effects.</div></div>","PeriodicalId":8966,"journal":{"name":"Biomedicine & Pharmacotherapy","volume":"181 ","pages":"Article 117689"},"PeriodicalIF":6.9000,"publicationDate":"2024-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Butyrate modulates gut microbiota and anti-inflammatory response in attenuating cisplatin-induced kidney injury\",\"authors\":\"Wen-Jung Chen ,&nbsp;Yng-Tay Chen ,&nbsp;Jiunn-Liang Ko ,&nbsp;Jian-Yuan Chen ,&nbsp;Jun-Yao Zheng ,&nbsp;Jiunn-Wang Liao ,&nbsp;Chu-Chyn Ou\",\"doi\":\"10.1016/j.biopha.2024.117689\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In our previous research, we reported that administering probiotics <em>Lactobacillus reuteri</em> and <em>Clostridium butyricum</em> (LCs) before cisplatin treatment effectively modifies structures of the gut microbiota and restore ecological balance and significantly increases butyrate levels, a process closely associated with reducing cisplatin-induced nephrotoxicity. This study aims to investigate further whether the elevation of metabolite butyrate in the gut, promoted by probiotics LCs, can effectively mitigate the nephrotoxic effects of cisplatin and the progression of renal senescence in rats. Results show that butyrate administration significantly improved kidney function and decreased renal fibrosis in a dose-dependent manner compared to the cisplatin group. Its effects were associated with reductions in inflammatory responses, evidenced by decreased levels of key inflammatory markers, including KIM-1, MPO, NOX2, F4/80, and TGF-β1, alongside increased production of the anti-inflammatory cytokine IL-10. Furthermore, the butyrate intervention ameliorated cisplatin-induced gut microbiota dysbiosis, preserving the structure and diversity of healthy microbial communities. Specifically, we observed a decrease in the abundance of <em>Escherichia_Shigella</em> and <em>Blautia</em>, alongside an increase in the abundance of the butyrate-producing genus <em>Roseburia</em>. Notably, <em>Escherichia_Shigella</em> exhibited a positive correlation with the pro-inflammatory factor MPO, while displaying a negative correlation with the anti-inflammatory cytokine IL-10. Butyrate also attenuated the cisplatin-induced expression of senescence markers p21 and p16 in kidney tissue. It alleviated the cisplatin-increased senescence-associated beta-galactosidase activity and reactive oxygen species production in SV40 MES-13 cells. These results indicate that butyrate, derived from the gut microbiota, may exert a protective effect against cisplatin-induced kidney damage by regulating microbiota balance and anti-inflammatory effects.</div></div>\",\"PeriodicalId\":8966,\"journal\":{\"name\":\"Biomedicine & Pharmacotherapy\",\"volume\":\"181 \",\"pages\":\"Article 117689\"},\"PeriodicalIF\":6.9000,\"publicationDate\":\"2024-11-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedicine & Pharmacotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0753332224015750\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0753332224015750","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

在之前的研究中,我们报道了在顺铂治疗前服用益生菌Lactobacillus reuteri和Clostridium butyricum(LCs)可有效改变肠道微生物群的结构,恢复生态平衡,并显著提高丁酸盐的水平,这一过程与减轻顺铂诱导的肾毒性密切相关。本研究旨在进一步探讨益生菌 LCs 促进肠道代谢物丁酸盐的升高是否能有效减轻顺铂的肾毒性效应和大鼠肾衰老的进程。结果表明,与顺铂组相比,丁酸盐能以剂量依赖的方式明显改善肾功能并减少肾纤维化。丁酸盐的作用与炎症反应的减少有关,主要炎症标志物(包括KIM-1、MPO、NOX2、F4/80和TGF-β1)水平的降低以及抗炎细胞因子IL-10产量的增加证明了这一点。此外,丁酸盐干预还能改善顺铂诱导的肠道微生物群失调,保护健康微生物群落的结构和多样性。具体来说,我们观察到石灰样肠杆菌(Escherichia_Shigella)和布劳氏菌(Blautia)的丰度下降,而丁酸菌属 Roseburia 的丰度上升。值得注意的是,志贺氏菌与促炎因子 MPO 呈正相关,而与抗炎细胞因子 IL-10 呈负相关。丁酸盐还能减轻顺铂诱导的肾组织中衰老标志物 p21 和 p16 的表达。它还减轻了顺铂增加的与衰老相关的 beta-半乳糖苷酶活性和 SV40 MES-13 细胞中活性氧的产生。这些结果表明,来自肠道微生物群的丁酸盐可通过调节微生物群平衡和抗炎作用,对顺铂诱导的肾损伤起到保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Butyrate modulates gut microbiota and anti-inflammatory response in attenuating cisplatin-induced kidney injury
In our previous research, we reported that administering probiotics Lactobacillus reuteri and Clostridium butyricum (LCs) before cisplatin treatment effectively modifies structures of the gut microbiota and restore ecological balance and significantly increases butyrate levels, a process closely associated with reducing cisplatin-induced nephrotoxicity. This study aims to investigate further whether the elevation of metabolite butyrate in the gut, promoted by probiotics LCs, can effectively mitigate the nephrotoxic effects of cisplatin and the progression of renal senescence in rats. Results show that butyrate administration significantly improved kidney function and decreased renal fibrosis in a dose-dependent manner compared to the cisplatin group. Its effects were associated with reductions in inflammatory responses, evidenced by decreased levels of key inflammatory markers, including KIM-1, MPO, NOX2, F4/80, and TGF-β1, alongside increased production of the anti-inflammatory cytokine IL-10. Furthermore, the butyrate intervention ameliorated cisplatin-induced gut microbiota dysbiosis, preserving the structure and diversity of healthy microbial communities. Specifically, we observed a decrease in the abundance of Escherichia_Shigella and Blautia, alongside an increase in the abundance of the butyrate-producing genus Roseburia. Notably, Escherichia_Shigella exhibited a positive correlation with the pro-inflammatory factor MPO, while displaying a negative correlation with the anti-inflammatory cytokine IL-10. Butyrate also attenuated the cisplatin-induced expression of senescence markers p21 and p16 in kidney tissue. It alleviated the cisplatin-increased senescence-associated beta-galactosidase activity and reactive oxygen species production in SV40 MES-13 cells. These results indicate that butyrate, derived from the gut microbiota, may exert a protective effect against cisplatin-induced kidney damage by regulating microbiota balance and anti-inflammatory effects.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
11.90
自引率
2.70%
发文量
1621
审稿时长
48 days
期刊介绍: Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信